These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 8486670

  • 1. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption.
    Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, Mintz KA, Robey PG, Teitelbaum SL, Cheresh DA.
    J Biol Chem; 1993 May 05; 268(13):9901-7. PubMed ID: 8486670
    [Abstract] [Full Text] [Related]

  • 2. Binding of osteopontin to the osteoclast integrin alpha v beta 3.
    Miyauchi A, Alvarez J, Greenfield EM, Teti A, Grano M, Colucci S, Zambonin-Zallone A, Ross FP, Teitelbaum SL, Cheresh D.
    Osteoporos Int; 1993 May 05; 3 Suppl 1():132-5. PubMed ID: 8461540
    [Abstract] [Full Text] [Related]

  • 3. Interaction of osteopontin with osteoclast integrins.
    Horton MA, Nesbit MA, Helfrich MH.
    Ann N Y Acad Sci; 1995 Apr 21; 760():190-200. PubMed ID: 7540373
    [Abstract] [Full Text] [Related]

  • 4. Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts.
    Miyauchi A, Alvarez J, Greenfield EM, Teti A, Grano M, Colucci S, Zambonin-Zallone A, Ross FP, Teitelbaum SL, Cheresh D.
    J Biol Chem; 1991 Oct 25; 266(30):20369-74. PubMed ID: 1939092
    [Abstract] [Full Text] [Related]

  • 5. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.
    Razzouk S, Brunn JC, Qin C, Tye CE, Goldberg HA, Butler WT.
    Bone; 2002 Jan 25; 30(1):40-7. PubMed ID: 11792563
    [Abstract] [Full Text] [Related]

  • 6. Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin.
    Helfrich MH, Nesbitt SA, Dorey EL, Horton MA.
    J Bone Miner Res; 1992 Mar 25; 7(3):335-43. PubMed ID: 1585836
    [Abstract] [Full Text] [Related]

  • 7. Bone sialoprotein coated on glass and plastic surfaces is recognized by different beta 3 integrins.
    Flores ME, Heinegård D, Reinholt FP, Andersson G.
    Exp Cell Res; 1996 Aug 25; 227(1):40-6. PubMed ID: 8806449
    [Abstract] [Full Text] [Related]

  • 8. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation.
    Duong LT, Rodan GA.
    Front Biosci; 1998 Aug 01; 3():d757-68. PubMed ID: 9682033
    [Abstract] [Full Text] [Related]

  • 9. Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption.
    Helfrich MH, Nesbitt SA, Lakkakorpi PT, Barnes MJ, Bodary SC, Shankar G, Mason WT, Mendrick DL, Väänänen HK, Horton MA.
    Bone; 1996 Oct 01; 19(4):317-28. PubMed ID: 8894137
    [Abstract] [Full Text] [Related]

  • 10. Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro.
    Grzesik WJ, Robey PG.
    J Bone Miner Res; 1994 Apr 01; 9(4):487-96. PubMed ID: 7518179
    [Abstract] [Full Text] [Related]

  • 11. Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis.
    Dresner-Pollak R, Rosenblatt M.
    J Cell Biochem; 1994 Nov 01; 56(3):323-30. PubMed ID: 7876325
    [Abstract] [Full Text] [Related]

  • 12. RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin.
    Flores ME, Norgård M, Heinegård D, Reinholt FP, Andersson G.
    Exp Cell Res; 1992 Aug 01; 201(2):526-30. PubMed ID: 1639145
    [Abstract] [Full Text] [Related]

  • 13. Bone sialoprotein stimulates in vitro bone resorption.
    Raynal C, Delmas PD, Chenu C.
    Endocrinology; 1996 Jun 01; 137(6):2347-54. PubMed ID: 8641185
    [Abstract] [Full Text] [Related]

  • 14. Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: integrin-dependent and -independent actions.
    Shankar G, Gadek TR, Burdick DJ, Davison I, Mason WT, Horton MA.
    Exp Cell Res; 1995 Aug 01; 219(2):364-71. PubMed ID: 7543851
    [Abstract] [Full Text] [Related]

  • 15. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.
    Horton MA, Taylor ML, Arnett TR, Helfrich MH.
    Exp Cell Res; 1991 Aug 01; 195(2):368-75. PubMed ID: 1712731
    [Abstract] [Full Text] [Related]

  • 16. Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity.
    Hruska KA, Rolnick F, Huskey M, Alvarez U, Cheresh D.
    Endocrinology; 1995 Jul 01; 136(7):2984-92. PubMed ID: 7540546
    [Abstract] [Full Text] [Related]

  • 17. Integrin function in osteoclasts.
    Rodan SB, Rodan GA.
    J Endocrinol; 1997 Sep 01; 154 Suppl():S47-56. PubMed ID: 9379137
    [Abstract] [Full Text] [Related]

  • 18. Ca2+ suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin alpha v beta 3.
    Hu DD, Hoyer JR, Smith JW.
    J Biol Chem; 1995 Apr 28; 270(17):9917-25. PubMed ID: 7537271
    [Abstract] [Full Text] [Related]

  • 19. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
    Mercer B, Markland F, Minkin C.
    J Bone Miner Res; 1998 Mar 28; 13(3):409-14. PubMed ID: 9525341
    [Abstract] [Full Text] [Related]

  • 20. Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone.
    Carron CP, Meyer DM, Engleman VW, Rico JG, Ruminski PG, Ornberg RL, Westlin WF, Nickols GA.
    J Endocrinol; 2000 Jun 28; 165(3):587-98. PubMed ID: 10828842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.